Skip To Main Content

Artiklar

Sort by

Filtrera

Återställ
  • Filtera
The Complex Burden of Autoimmune Type 1 Diabetes

The Complex Burden of Autoimmune Type 1 Diabetes

Uncovering the Hidden Burden: Understanding Loss of Smell in CRSwNP

Uncovering the Hidden Burden: Understanding Loss of Smell in CRSwNP

Navigating the Complexities of Smell Loss in Patients with CRSwNP.

The Long-Term Impact of Early-Onset Atopic Dermatitis

The Long-Term Impact of Early-Onset Atopic Dermatitis

A recent study led by professor Jonathan Silverberg involving over 30,000 participants has highlighted the significant psychosocial burden faced by adults with early-onset atopic dermatitis (AD). Learn more and continue reading.

Long-Term Efficacy and Safety of Dupixent in Moderate-to-Severe Atopic Dermatitis: 5-Year Open-Label Extension Study Results<sup>1</sup>

Long-Term Efficacy and Safety of Dupixent in Moderate-to-Severe Atopic Dermatitis: 5-Year Open-Label Extension Study Results

Atopic dermatitis (AD) is a chronic inflammatory skin condition that can significantly impact patients' quality of life. Dupixent (dupilumab) has emerged as a treatment for moderate-to-severe AD. This article summarizes the findings of a 5-year open-label extension study (Beck et al, 2024), providing insights into the long-term efficacy and safety profile of Dupixent for dermatologists managing patients with persistent AD.

Global Developments in Early Detection<br />of Autoimmune Type 1 Diabetes

Global Developments in Early Detection of Autoimmune Type 1 Diabetes

Curious about the characteristics of pre-symptomatic- and stage 3 Type 1 Diabetes? Interested in learning about the potential benefits of screening for autoimmune Type 1 Diabetes?

This short film gives you an overview of recent developments in diagnosis of Type 1 Diabetes, showcasing how early detection efforts can benefit those who need it the most.

146 for Lipid Management After ACS

146 for Lipid Management After ACS

2024 ESC Guidelines for the management of chronic coronary syndromes

2024 ESC Guidelines for the management of chronic coronary syndromes

Felicita Andreotti, Italy; Christiaan J M Vrints, Belgium

Påverkan av exacerbationer vid KOL

Påverkan av exacerbationer vid KOL

Livskvalitet och symtommätning hos KOL-patienter

Livskvalitet och symtommätning hos KOL-patienter

En minut för att sprida ljus över nya möjligheter inom KOL

En minut för att sprida ljus över nya möjligheter inom KOL

Att förstå typ 2-inflammation* kan hjälpa till att belysa varför vissa patienter fortsätter att få exacerbationer. Titta på denna video för att lära dig hur.1

Typ 2-inflammationens roll*

Typ 2-inflammationens roll

Detectability of Autoimmune Type 1 Diabetes

Detectability of Autoimmune Type 1 Diabetes

Systematic early detection of autoimmune Type 1 Diabetes might be a new way to avoid acute and chronic complications of the condition.1-5 This new approach may play a role as a revolutionary shift, helping to shape the future of Type 1 Diabetes management.2